Pfizer
American multinational pharmaceutical corporation
Positive
Negative
Entity sentiment
Reports
News
Opinions
Statements
Relations
business Feb 17, 2026, 6:20 PM
Pfizer's CEO claims vaccine saved the world amid backlash over statements - In early 2022, many countries were still enforcing COVID-related restrictions.
- Albert Bourla claimed Pfizer's vaccine was the key to reversing pandemic policies.
- The vaccine, however, did not meet initial efficacy claims and sparked significant debate.
100
business Feb 4, 2026, 9:24 PM
Pfizer's weight loss drug shows promising trial results - Pfizer's experimental weight loss drug, PF-08653944, showed solid results in a mid-stage clinical trial with no observed plateau in weight loss by week 28.
- The drug's side effects were predominantly mild or moderate, with a few patients discontinuing treatment due to adverse effects.
- These findings position Pfizer to compete in the weight loss drug market against other companies like Amgen and Eli Lilly.
100
business Jan 27, 2026, 1:00 AM
Pfizer aims to revolutionize cancer treatment under Albert Bourla's leadership - Albert Bourla, CEO of Pfizer, is steering the company towards new drug developments after the COVID-19 pandemic.
- Pfizer's revenue has declined to around $5 billion, prompting a strategic focus on innovative treatment options.
- The company's future ambitions include transforming cancer into a manageable condition and leveraging AI in drug development.
100
science Dec 16, 2025, 11:15 PM
FDA warns about meningioma risk in Depo-Provera label change - The FDA approved a warning label change for Pfizer's Depo-Provera in December 2025.
- Pfizer faces a lawsuit from over 1,000 women alleging failure to warn about risks.
- The updated label aims to inform patients of the risk of meningioma, addressing a long-standing concern.
100
science Nov 19, 2025, 11:02 PM
Pfizer's mRNA flu vaccine shows superior results in clinical trial - In a Phase 3 trial, over 18,000 adults received either Pfizer's mRNA flu vaccine or a standard flu shot during the 2022-2023 flu season.
- The mRNA vaccine showed approximately 27% higher efficacy than the traditional flu vaccine, although it also resulted in more side effects.
- These findings indicate the mRNA shot's potential as a new approach for influenza prevention.
100
2026 All rights reserved
2026 All rights reserved